Filter
1830
Filtered Results: 1830
Text search:
World
Health
Organization,
Regional
Office
for
the
Americas
Featured
Recommendations
186
New Publications
391
Language
Document type
No document type
869
Studies & Reports
439
Guidelines
237
Manuals
128
Strategic & Response Plan
64
Training Material
41
Situation Updates
21
Fact sheets
17
Resource Platforms
8
Infographics
3
Online Courses
2
App
1
Countries / Regions
Global
128
Latin America and the Carribbean
64
Western and Central Europe
36
India
26
Liberia
23
Africa
23
Ethiopia
20
Syria
18
Sierra Leone
17
Ukraine
17
Venezuela
17
Uganda
16
Haiti
16
South Africa
15
Myanmar / Burma
15
Asia
15
Eastern Europe
15
South–East Asia Region
13
Russia
13
Middle East and North Africa
12
Nigeria
11
Ghana
11
Kenya
11
Colombia
11
Philippines
10
South Sudan
10
Brazil
10
Nepal
9
Zambia
9
Tanzania
9
Bangladesh
9
Afghanistan
8
Rwanda
8
Guinea
7
Congo, Democratic Republic of
7
Pakistan
7
East and Southern Africa
7
West and Central Africa
7
Eastern Europe and Central Asia
7
Zimbabwe
6
Somalia
6
Jordan
6
Thailand
6
Malawi
6
Mozambique
6
Namibia
6
Peru
6
USA
5
Indonesia
5
Western Pacific Region
5
Paraguay
5
Iran
5
Cambodia
4
China
4
Eswatini/ Swaziland
4
Ecuador
4
Senegal
3
Mali
3
Germany
3
Lebanon
3
Papua New Guinea
3
Central African Republic
3
Madagascar
3
Mexico
3
Yemen
3
Albania
3
Iraq
2
Sudan
2
Argentina
2
North Macedonia
2
Botswana
2
Bolivia
2
Greece
2
Palestine
2
Armenia
2
Canada
2
Tajikistan
2
Estonia
2
Moldova
2
Kyrgyzstan
2
Georgia
2
Vietnam
2
North America
2
Jamaica
2
Burkina Faso
1
Guinea-Bissau
1
Côte d’Ivoire / Ivory Coast
1
Morocco
1
Saudi Arabia
1
Cameroon
1
Niger
1
Turkey
1
Malaysia
1
Vanuatu
1
Croatia
1
Honduras
1
El Salvador
1
Libya
1
Guatemala
1
Lesotho
1
Chile
1
Other region
1
Solomon Islands
1
North Korea
1
Laos
1
Timor Leste/ East Timor
1
Qatar
1
Romania
1
Kazakhstan
1
Turkmenistan
1
Belgium
1
Tunisia
1
United Kingdom
1
Belarus
1
Authors & Publishers
Publication Years
Category
Countries
337
Clinical Guidelines
202
Public Health
142
Women & Child Health
130
Key Resources
102
Capacity Building
32
Pharmacy & Technologies
25
Toolboxes
Mental Health
195
HIV
179
COVID-19
149
Planetary Health
121
Rapid Response
97
Disability
80
TB
78
Global Health Education
63
NTDs
59
Zika
56
AMR
56
Caregiver
51
Refugee
48
Conflict
40
Pharmacy
35
NCDs
35
Natural Hazards
30
Health Financing Toolbox
28
Ebola
27
Specific Hazards
11
Cholera
7
Polio
6
Social Ethics
3
Typhoon
2
Report of the 23rd WHO Expert Committee on the selection and use of essential medicines
This executive summary reports the recommendations made by...
Interium guidance, 25 June 2021Timely and accurate diagnostic testing is an essential tool in preventing and controlling the spread of COVID-19. This document describes recommendations for national ...
This adaptation and implementation guide is part of a five-part Caregiver skills training for families of children with developmental delays or disabilities (CST) package providing guidance on caregiver skills training ... families of children aged 2–9 years with developmental delays or disabilities.
This adaptation and implementation guide provides information on how to adapt caregiver skills training materials and delivery strategies to the local context. It includes guidance on development and implementation of contextual and cultural adaptation plans.
The Guidance on global monitoring for diabetes prevention and control by WHO provides a comprehensive framework to support countries in tracking and managing diabetes prevention, care, and outcomes....
Background: The World Health Organization (WHO) published a clinical case definition of post COV...
A all for global Action. The Oral Health Atlas. Second edition
These guidelines deal specifically with water, sanitation and hygiene, and are designed to be used in schools in low-cost settings in low- and medium-resource countries to:
• assess prevailing situations and plan for required improvements;
• ...
There is a substantial and ever-increasing unmet need for rehabilitation worldwide, which is particularly profound in low- and middle
-income countries. The availability of accessible and affordabl...
Interim rapid response guidance, 10 June 2022.
It includes considerations for certain populations such as patients with mild disease with considerations for community care, patients with moderate t...
Medical devices are used for the prevention, diagnosis and treatment of illness and diseases and for rehabilitation. WHO developed guidance on medi...
This volume contains monographs prepared at the ninety-first meeting of the Joint FAO/WHO Expert Committee on Food Additives (JECFA), which met virtually online from 1 to 12 February 2021.
... detailed monographs in this volume summarize data on specific contaminants in food. Individual monographs present the assessment of exposure to cadmium from all food sources, the technical, analytical, dietary exposure and toxicological data on ergot alkaloids, an assessment of five substances that may occur as previous cargoes, and a revision of the specifications for steviol glycosides. This volume and others in the WHO Food Additives series contain information that is useful to those who produce and use food additives and veterinary drugs and those involved with controlling contaminants in food, government and food regulatory officers, industrial testing laboratories, toxicological laboratories and universities.
This document is intended for a wide audience including national and local policymakers, implementers and managers of national and local maternal and child health programmes, non-governmental and ot...
The WHO continuously reviews available data on SARS-CoV-2 variants of concern. For this version, the global epidemiological
situation of ... COVID-19 pandemic as of 21 January 2022 – at a time when the Omicron VOC had been identified in 171
countries across all six WHO Regions and was rapidly replacing Delta worldwide – was considered Omicron has a substantial growth advantage, higher secondary attack rates and a higher observed reproduction number than Delta.
There is now significant evidence that immune evasion contributes to the rapid spread of Omicron. Other factors may be a shorter
serial interval (by about 0.8 to 1.2 days compared to Delta) and potential increased intrinsic transmission fitness . There is
growing evidence that with Omicron, there is lower vaccine effectiveness (VE) against infection and symptomatic disease soon after vaccination compared to Delta. There is also evidence of accelerated waning of VE over time of the primary series against infection and symptomatic disease for the studied vaccines. Further studies are required to better understand the drivers of transmission and declining incidence in various settings. These factors include the intrinsic transmission fitness properties of the virus, degree of immune evasion, vaccination coverage and level of vaccine-derived and post-infection immunity, levels of social mixing and degree of application of public health and social measures (PHSM).
The aim of this “model contingency plan” is to assist programme managers and planners in devel-oping a national, context-specific, dengue outbreak response plan in order to: (a) detect a dengue outbreak at an early stage through clearly defined ...
The objectives of these guidelines are to provide recommendations outlining a public health approach to managing people presenting with advanced HIV disease, and to provide guidance on ... timing of initiation of antiretroviral therapy (ART) for all people living with HIV.
WHO recommends that a package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
WHO recommends that a package of screening, prophylaxis, rapid ART initiation and intensified adherence interventions be offered to everyone living with HIV presenting with advanced disease.
WHO strongly recommends that rapid ART initiation should be offered to people living with HIV following confirmed diagnosis and clinical assessment. Rapid initiation of ART is defined as within seven days of HIV diagnosis. WHO further strongly recommends ART initiation on the same day as HIV diagnosis based on the person’s willingness and readiness to start ART immediately, unless there are clinical reasons to delay treatment.
Small drinking-water supplies commonly experience operational, managerial, technical and resourcing challenges that impact their ability to deliver safe and reliable services. The needs and opportunities associated with these supplies therefore warr...
In light of the decline in new Ebola cases, strategies are now needed to scale down the activities and bed capacities in Ebola care facilities. These facilities include Ebola treatment units, commun...
Every year, around 830 000 children die from unintentional or "accidental" injuries. The vast majority of these injuries occur in low-income and middle-income countries. However, dozens of prevention strategies and programmes exist. If they were int...
Validation of elimination of mother-to-child transmission, or vertical transmission, of HIV, syphilis and hepatitis B virus (HBV), is an attestation that a country has successfully met standard criteria for elimination, or ... being at 1 of the 3 levels of achievement on the ‘Path to Elimination’ while delivering quality services for women, girls and their children, through the life-course, respecting human rights and ensuring gender equality and community engagement.
This document, the third version, adds on EMTCT of hepatitis B virus (HBV), bringing together a package of interventions and metrics to support integrated management and monitoring of vertical transmission across a wide range of epidemiological and programmatic contexts.
This document, the third version, adds on EMTCT of hepatitis B virus (HBV), bringing together a package of interventions and metrics to support integrated management and monitoring of vertical transmission across a wide range of epidemiological and programmatic contexts.
Lack of trained providers capable of identifying which labouring women could benefit from assisted vaginal birth (AVB), and of safely performing the procedure is a major barrier for its use. Educati...
